Literature DB >> 3707637

Cyclosporin A is effective, but not safe, in the management of Behçet's disease.

B Wechsler, E B Mertani, P le Hoang, F de Groc, J C Piette, H Beaufils, B Aupetit, H le Minh, J Rottembourg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3707637     DOI： 10.1002/art.1780290420

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  3 in total

1.  Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial.

Authors:  Y Ozyazgan; S Yurdakul; H Yazici; B Tüzün; A Işçimen; Y Tüzün; T Aktunç; H Pazarli; V Hamuryudan; A Müftüoğlu
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

Review 2.  Update on the therapy of Behçet disease.

Authors:  Zeinab Saleh; Thurayya Arayssi
Journal:  Ther Adv Chronic Dis       Date:  2014-05       Impact factor: 5.091

3.  Electrophysiological and MRI evaluation of neurological involvement in Behçet's disease.

Authors:  C Besana; G Comi; A Del Maschio; L Praderio; A Vergani; S Medaglini; V Martinelli; F Triulzi; T Locatelli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.